Ali Hariri

Ali Hariri, M.D., is Eloxx’s Chief Medical Officer, responsible for overseeing clinical development efforts for the company’s promising pipeline of therapies to treat rare diseases. Prior to joining Eloxx, Dr. Hariri served as Senior Global Project Head in Rare Disease Clinical Development at Sanofi-Genzyme where he oversaw key functions responsible for advancing a number of investigational therapies along with approval of supplemental indications for on-market therapies.

Prior to his role as Global Project Head at Sanofi-Genzyme, Dr. Hariri held several positions of increasing responsibility with expertise across a range of therapeutic areas including renal and immunology. Before joining Sanofi, Dr. Hariri held clinical development and medical affairs roles at Ionis and Takeda coordinating publication planning and health economics research. Dr. Hariri was also a practicing nephrologist.